A roundup of the week’s most newsworthy health industry press releases from PR Newswire, including a mental health startup focused on culturally-responsive care. NEW YORK, June 16, 2023 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the … Read more
DUBLIN, June 16, 2023 /PRNewswire/ — The “Specialty Enzymes Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Proteases, Polymerases & Nucleases, Carbohydrase’s, Lipases, and Others), By Source, By Application, By Region” report has been added to ResearchAndMarkets.com’s offering. Global Specialty Enzymes Market is anticipated to witness a robust CAGR in the … Read more
Poster on FP-020, a follow-on, best-in-class, oral MMP-12 inhibitor in a genetic model of sarcoidosis includes efficacy, biomarkers and complete translational cellular profiling supporting novel anti-inflammatory and anti-fibrotic mechanism TAIPEI, June 16, 2023 /PRNewswire/ — Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the company will be participating and presenting a poster at the WASOG 2023 … Read more
SHANGHAI, June 16, 2023 /PRNewswire/ — Cholesgen (Shanghai) Co.Ltd. (‘Cholesgen’) today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint research effort will leverage complementary strengths and focus on selected targets … Read more
SHANGHAI, June 16, 2023 /PRNewswire/ — Cholesgen (Shanghai) Co.Ltd. (‘Cholesgen’) today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint research effort will leverage complementary strengths and focus on selected targets … Read more
DUBLIN, June 16, 2023 /PRNewswire/ — The “Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023” report has been added to ResearchAndMarkets.com’s offering. This report takes a deep dive into the Chinese innovative biopharmaceutical market, providing groundbreaking insights into clinical development trends, activity, budget growth and preferences. The report also details clinical development outsourcing preferences and … Read more
DUBLIN, June 16, 2023 /PRNewswire/ — The “Environmental Test Chamber: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global market for environmental test chambers was estimated to be $864.3 million in 2022. It is projected that the environmental test chamber market will grow at a CAGR of 2.5% and is forecast to reach $1.1 … Read more
COLOGNE, Germany, June 16, 2023 /PRNewswire/ — “We care for your samples, you care for science” – Singleron holds true to their slogan as reliable partner to scientists and clinicians. Developing single cell multi-omics products that can be used in research and clinical settings, the launch of two new instruments extends their current portfolio that … Read more
HAMBURG, Germany, June 16, 2023 /PRNewswire/ — A recent study conducted in Belgium has revealed the potential effects of air pollution on the airways of early-career elite athletes. While physical exercise is known to improve overall health, the study suggests that intense physical activity in a polluted environment may act as a stressor to the airway … Read more
HAMBOURG, Allemagne, 16 juin 2023 /PRNewswire/ — Une étude récente menée en Belgique a révélé les effets potentiels de la pollution atmosphérique sur les voies respiratoires des athlètes de haut niveau en début de carrière. Alors que l’exercice physique est connu pour améliorer la santé en général, l’étude suggère qu’une activité physique intense dans un … Read more